# K024097: Summit Medical LTD Celltrans Postoperative Autotransfusion Set, Models AB400-10, AB400-12, AB400-14

- Pathway: 510(k) (Traditional)
- Applicant: Summit Medical, Ltd.
- Decided: Feb 14, 2003 after 64 days
- Product code: CAC (Apparatus, Autotransfusion)
- Device class: 2
- Regulation: 21 CFR 868.5830
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K951592 (1996). 4 ancestors in all.
7 later devices descend from it; 1 cites it directly.
0 of 12 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K022489: Summit Medical LTD Celltrans Postoperative Autotransfusion System, Models ABT4510, ABT4512 & ABT4514, Summit Medical, Ltd. (2002) Summary page 2.
- K022477: Summit Medical LTD Transfusion Filter, Model LF400 & Summit Medical LTD Transfusion Filter with Administration Set, Summit Medical, Ltd. (2002) Summary page 2.

## Most influential descendants
- K210176: FlowSaver Blood Filter (2021), 6 descendants of its own
- K240426: Aventus Clot Management System (2024), 3 descendants of its own
- K253925: Aventus Thrombectomy System (2026), 2 descendants of its own
- K221483: FlowSaver Blood Return System (2023), 1 descendant of its own
- K261105: Powered Aventus Thrombectomy System™ (2026), 0 descendants of its own

## Indications for use
The Summit Medical CellTransTMPostoperative Autotransfusion Set is intended for the collection, filtration and reinfusion of blood lost postoperatively following surgery, particularly orthopaedic joint replacement. The device is indicated for autologous blood transfusion.

Source page: https://510kreport.com/device/K024097
Methodology: https://510kreport.com/methodology